FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

374761007: Caffeine citrate 20mg/mL injection solution ampule (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1213140010 Caffeine citrate 20mg/mL injection en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1458403014 Caffeine citrate 20mg/mL injection solution ampule (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1475826013 Caffeine citrate 20mg/mL injection solution ampoule en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1476782011 Caffeine citrate 20mg/mL injection solution ampule en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    4649141000005114 caffeincitrat 20 mg/ml injektionsvæske, opløsning, ampul da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    caffeincitrat 20 mg/ml injektionsvæske, opløsning, ampul Is a Product containing caffeine (medicinal product) false Inferred relationship Some
    caffeincitrat 20 mg/ml injektionsvæske, opløsning, ampul Is a Respiratory AND/OR cerebral stimulant false Inferred relationship Some
    caffeincitrat 20 mg/ml injektionsvæske, opløsning, ampul Is a Product containing caffeine in parenteral dose form (medicinal product form) false Inferred relationship Some
    caffeincitrat 20 mg/ml injektionsvæske, opløsning, ampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Caffeine citrate (substance) false Inferred relationship Some
    caffeincitrat 20 mg/ml injektionsvæske, opløsning, ampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Caffeine false Inferred relationship Some
    caffeincitrat 20 mg/ml injektionsvæske, opløsning, ampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bronchodilator (substance) false Inferred relationship Some
    caffeincitrat 20 mg/ml injektionsvæske, opløsning, ampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Stimulant (substance) false Inferred relationship Some
    caffeincitrat 20 mg/ml injektionsvæske, opløsning, ampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Xanthine false Inferred relationship Some
    caffeincitrat 20 mg/ml injektionsvæske, opløsning, ampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Phosphodiesterase inhibitor false Inferred relationship Some
    caffeincitrat 20 mg/ml injektionsvæske, opløsning, ampul Has manufactured dose form injektionsvæske false Inferred relationship Some
    caffeincitrat 20 mg/ml injektionsvæske, opløsning, ampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Xanthine false Inferred relationship Some
    caffeincitrat 20 mg/ml injektionsvæske, opløsning, ampul Has manufactured dose form Solution for injection false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start